Atlas Trials

A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Clinical trial NCT05337254 · COMPLETED

Trial details

NCT number
NCT05337254
Sponsor
Satsuma Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MigraineMigraine With AuraMigraine Without Aura
Start date
2021-03-05
Primary completion
2021-06-04
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.